A Drug Interaction Study of JNJ-31001074 and Ketoconazole in Healthy Volunteers
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This is an open-label (both the physician and healthy volunteer know which treatment will be
administered) study to assess the pharmacokinetics (process by which JNJ-31001074 is
absorbed, distributed, metabolized, and eliminated by the body) of JNJ-31001074 when taken
alone and in combination with ketoconazole. The study consists of three phases: a screening
phase to determine eligibility, an open-label treatment phase consisting of three periods and
an end-of study/early withdrawal assessment phase.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.